Altered Processing of Amyloid Precursor Protein in Cells Undergoing Apoptosis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Fiorelli, Tina ^a,b   Kirouac, Lisa ^a,b   Padmanabhan, Jaya ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE 3; CASPASE 7; MATRIX METALLOPROTEINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GLIOMA CELL; IMMUNOREACTIVITY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; RAT;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; CAMPTOTHECIN; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA DAMAGE; ENZYME ACTIVATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEURONS; PEPTIDE FRAGMENTS; PREGNANCY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RATS; RNA, SMALL INTERFERING;

EID: 84874555846     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057979     Document Type: Article

References (56)

1. Glenner GG, Wong CW, (1984) Alzheimers-disease- initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890.
2. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
3. Allinson TM, Parkin ET, Turner AJ, Hooper NM, (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res 74: 342-352.
4. Nitsch RM, Wurtman RJ, Growdon JH, (1995) Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease. Arzneimittel-Forschung 45: 435-438.
5. Zhao M, Su J, Head E, Cotman CW, (2003) Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Neurobiol of Dis 14: 391-403.
6. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97: 395-406.
7. Siman R, Card JP, Davis LG, (1990) Proteolytic processing of beta-amyloid precursor by calpain I. J Neurosci 10: 2400-2411.
8. Hart MJ, Glicksman M, Liu M, Sharma MK, Cuny G, et al. (2012) Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein. Anal Biochem 421: 467-476.
9. Ayala-Grosso C, Ng G, Roy S, Robertson GS, (2002) Caspase-cleaved amyloid precursor protein in Alzheimer's disease. Brain Pathol 12: 430-441.
10. Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, et al. (2002) Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 82: 283-294.
11. Tesco G, Koh YH, Tanzi RE, (2003) Caspase activation increases beta-amyloid generation independently of caspase cleavage of the beta-amyloid precursor protein (APP). J Biol Chem 278: 46074-46080.
12. Cotman CW, Su JH, (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 6: 493-506.
13. Milligan CE, (2000) Caspase cleavage of APP results in a cytotoxic proteolytic peptide. Nat Med 6: 385-386.
14. Bertrand E, Brouillet E, Caille I, Bouillot C, Cole GM, et al. (2001) A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol Cell Neurosci 18: 503-511.
15. Fiorelli T, Padmanabhan J, (2011) Mechanisms of cell death in Alzheimer's disease. Alfomine: Int J Res Discourse 1: 1-11.
16. Pompl PN, Yemul S, Xiang Z, Ho L, Haroutunian V, et al. (2003) Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch Neurol 60: 369-376.
17. Pellegrini L, Passer BJ, Tabaton M, Ganjei JK, D'Adamio L, (1999) Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and-8. J Biol Chem 274: 21011-21016.
18. Padmanabhan J, Levy M, Dickson DW, Potter H, (2006) Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain 129: 3020-3034.
19. Park DS, Morris EJ, Bremner R, Keramaris E, Padmanabhan J, et al. (2000) Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci 20: 3104-3114.
20. Park DS, Morris EJ, Greene LA, Geller HM, (1997) G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci 17: 1256-1270.
21. Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, et al. (1998) Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci 18: 830-840.
22. Judge M, Hornbeck L, Potter H, Padmanabhan J, (2011) Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes. Mol Neurodegener 6: 80.
23. Murphy MP, Uljon SN, Fraser PE, Fauq A, Lookingbill HA, et al. (2000) Presenilin 1 regulates pharmacologically distinct gamma-secretase activities. Implications for the role of presenilin in gamma-secretase cleavage. J Biol Chem 275: 26277-26284.
24. Padmanabhan J, (2009) Detection of histone H3 phosphorylation in cultured cells and tissue sections by immunostaining. Methods Mol Biol 523: 311-322.
25. Morris EJ, Geller HM, (1996) Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 134: 757-770.
26. Hsiang YH, Hertzberg R, Hecht S, Liu LF, (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase-I. J Biol Chem 260: 4873-4878.
27. Chen X, Ko LJ, Jayaraman L, Prives C, (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10: 2438-2451.
28. Nelson WG, Kastan MB, (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14: 1815-1823.
29. McDonald AC, Brown R, (1998) Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors. Br J Cancer 78: 745-751.
30. D'Onofrio G, Tramontano F, Dorio AS, Muzi A, Maselli V, et al. (2011) Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells. Biochem Pharmacol 81: 194-202.
31. Li X, Darzynkiewicz Z, (2000) Cleavage of Poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis. Exp Cell Res 255: 125-132.
32. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, et al. (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274: 22932-22940.
33. Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, et al. (1997) Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 17: 553-562.
34. Jiang ZH, Wu JY, (1999) Alternative splicing and programmed cell death. Proc Soc Exp Biol Med 220: 64-72.
35. Wee LJ, Tan TW, Ranganathan S, (2007) CASVM: web server for SVM-based prediction of caspase substrates cleavage sites. Bioinformatics 23: 3241-3243.
36. Mattson MP, Gary DS, Chan SL, Duan W, (2001) Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem Soc Symp pp. 151-162.
37. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-357.
38. Cattepoel S, Hanenberg M, Kulic L, Nitsch RM, (2011) Chronic intranasal treatment with an anti-Abeta(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 6: e18296.
39. Liu P, Kemper LJ, Wang J, Zahs KR, Ashe KH, et al. (2011) Grape seed polyphenolic extract specifically decreases abeta*56 in the brains of Tg2576 mice. J Alzheimers Dis 26: 657-666.
40. Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, et al. (2008) Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am J Pathol 172: 1683-1692.
41. Portelius E, Brinkmalm G, Tran AJ, Zetterberg H, Westman-Brinkmalm A, et al. (2009) Identification of novel APP/Abeta isoforms in human cerebrospinal fluid. Neurodegener Dis 6: 87-94.
42. Lu DC, Soriano S, Bredesen DE, Koo EH, (2003) Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity. J Neurochem 87: 733-741.
43. Nguyen TV, Galvan V, Huang W, Banwait S, Tang H, et al. (2008) Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 104: 1065-1080.
44. Su JH, Kesslak JP, Head E, Cotman CW, (2002) Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta neuropathologica 104: 1-6.
45. Soriano S, Lu DC, Chandra S, Pietrzik CU, Koo EH, (2001) The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases. J Biol Chem 276: 29045-29050.
46. Edelmann B, Bertsch U, Tchikov V, Winoto-Morbach S, Perrotta C, et al. (2011) Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J 30: 379-394.
47. Cuesta A, Zambrano A, Royo M, Pascual A, (2009) The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP). Biochem J 418: 643-650.
48. Lamkanfi M, Kanneganti TD, Van Damme P, Vanden Berghe T, Vanoverberghe I, et al. (2008) Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell Proteomics: MCP 7: 2350-2363.
49. Bravarenko NI, Onufriev MV, Stepanichev MY, Ierusalimsky VN, Balaban PM, et al. (2006) Caspase-like activity is essential for long-term synaptic plasticity in the terrestrial snail Helix. Eur J Neurosci 23: 129-140.
50. Chan SL, Mattson MP, (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58: 167-190.
51. D'Amelio M, Cavallucci V, Cecconi F, (2010) Neuronal caspase-3 signaling: not only cell death. Cell Death Differ 17: 1104-1114.
52. D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, et al. (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 14: 69-76.
53. Chan SL, Furukawa K, Mattson MP, (2002) Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med 2: 167-196.
54. Li HL, Roch JM, Sundsmo M, Otero D, Sisodia S, et al. (1997) Defective neurite extension is caused by a mutation in amyloid beta/A4 (A beta) protein precursor found in familial Alzheimer's disease. J Neurobiol 32: 469-480.
55. Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, et al. (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28: 14537-14545.
56. Chen QS, Kagan BL, Hirakura Y, Xie CW, (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60: 65-72.